Syringomyelia in the Cavalier King Charles spaniel (CKCS) dog

Canadian Veterinary Journal

Volumn 51, Issue 1, 2010, Pages 95-102

  Wolfe, Katheryn C ^a   Poma, Roberto ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; AMINE; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; GABAPENTIN; PREDNISONE;

ANIMAL; ANIMAL DISEASE; ARNOLD CHIARI MALFORMATION; ARTICLE; BREEDING; CASE REPORT; DISEASE COURSE; DOG; DOG DISEASE; FEMALE; GENETIC PREDISPOSITION; GENETICS; HOSPITALIZATION; MALE; PAIN; PATHOLOGY; PROGNOSIS; QUALITY OF LIFE; SYRINGOMYELIA;

AMINES; ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ARNOLD-CHIARI MALFORMATION; BREEDING; CYCLOHEXANECARBOXYLIC ACIDS; DISEASE PROGRESSION; DOG DISEASES; DOGS; FEMALE; GAMMA-AMINOBUTYRIC ACID; GENETIC PREDISPOSITION TO DISEASE; MALE; PAIN; PREDNISONE; PROGNOSIS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SYRINGOMYELIA;

CANIS FAMILIARIS;

EID: 77249144061     PISSN: 00085286     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Rusbridge C, Jeffery ND. Pathophysiology and treatment of neuropathic pain associated with syringomyelia. Vet J 2008;175:164-172.
2. Rusbridge C, Greitz D, Iskandar BJ. Syringomyelia: Current concepts in pathogensis, diagnosis and treatment. JVIM 2006;20:469-479.
3. Rusbridge C, Knowler SP. Inheritance of occipital bone hypoplasia (Chiari type I malformation) in Cavalier King Charles spaniels. J Vet Intern Med 2004;18:673-678.
4. Taga A, Taura T, Nakaichi N, Wada N, Hasegawa T. Magnetic resonance imaging of syringomyelia in five dogs. J Small Anim Prac 2000;41:362-365.
5. Jung DI, Park C, Kang BT, et al. Acquired cervical syringomyelia secondary to a brainstem meningioma in a maltese dog. Vet Med Sci 2006;68:1235-1238.
6. Costa RC, Parent JM, Poma R, Duque MC. Cervical syringohydromyelia secondary to a brainstem tumor in a dog. J Am Vet Med Assoc 2004;225:1061-1064.
7. Rusbridge C, Knowler SP. Hereditary aspects of occipital bone hypoplasia and syringomyelia (chiari-like malformation) in Cavalier King Charles spaniels. Vet Rec 2003;153:107-112.
8. Cauzinille L, Kornegay JN. Acquired syringomyelia in a dog. J Am Vet Med Assoc. 1992;201:1225-1228.
9. Schmahl W, Kaiser E. Hydrocephalus, syringomyelia, and spinal cord angiodysgenesis in a lhasa apso dog. Vet Pathol 1984;21:252-254.
10. Furneaux RW, Doige CE, Kaye MM. Syringomyelia and spina bifida occulta in a Samoyed dog. Can Vet J. 1973;14:317-321.
11. Lu D, Lamb CR, Pfeiffer M, Targett P. Neurologic signs and results of magnetic resonance imaging in 40 Cavalier King Charles spaniels with chiari type I-like malformations. Vet Rec 2003:260-263.
12. Nolon AM. Pharmacology of analgesic drugs. In: Flecknell PA, Waterman-Pearson A, eds. Pain Management in Animals. WB Saunders, London, 2000:21-52.
13. Barnes PJ. Anti-inflammatory actions of glucocorticoids: Molecular mechanisms. Clin Sci 1998;94:557-572.
14. Wong HK, Tan KJ. Effects of corticosteroids on nerve root recovery after spinal nerve root compression. Clin Orthop 2002;403:248-252.
15. Backonja MM. Use of anticonvulsants for the treatement of neuropathic pain. Neurology 2002;59:14-17.
16. Gray P, William B, Cramond T. Successful use of gabapentin in acute pain management following burn injury: A case series. Pain Med 2008;9:371-376.
17. Coderre TJ, Kumar N, Lefebvre CD, Yu JS. Evidence that gabapentin reduces neuropathic pain by inhibiting the spinal release of glutamate. J Neurochem 2005;94:1131-1139.
18. Gee NS, Brown JP, Dissanayake VU, Offord J, Thurlow R, Woodruff GN. The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel. J Biol Chem 1996;271:5768-5776.
19. Shimoyama M, Shimoyama N, Hori, Y. Gabapentin affects glutamatergic excitatory neurotransmission in the rat dorsal horn. Pain 2000;85:405-414.
20. Klekamp J. The pathophysiology of syringomyelia - historical overview and current concept. Acta Neurochir (Wien) 2002;144:649-664.
21. Milhorat TS, Capocelli AL, Anzil AP, Kotzen RM, Milhorat RH. Pathological basis of spinal cord cavitation in syringomyelia: Analysis of 105 autopsy cases. J Neurosurg 1995;82:802-812.
22. Williams H. A unifying hypothesis for hydrocephalus, chiari malformation, syringomyelia, anencephaly and spina bifida. Cerebrospinal Fluid Res 2008;5:7.
23. Greitz D, Hellwig D, Krauss J, et al. Unraveling the riddle of syringomyelia. Neurosurg Rev 2006;294;251-264.
24. Josephson A, Greitz D, Klason T, Olson L, Spenger C. A spinal thecal sac constriction model supports the theory that induced pressure gradients in the cord cause edema and cyst formation. Neurosurgery. 2001;48:636-646.
25. Greitz D. CSF flow at the craniocervical junction: Increased systolic and diastolic pressure gradients as the cause of cystic cord lesions. In: Kenez J, ed. Imaging of the Craniocervical Junction. Udine Milano, Edizione del Centauro, (1995)19-23.
26. Levine D. The pathogenesis of syringomyelia associated with lesions at the foramen magnum: A critical review of existing theories and proposal of a new hypothesis. J Neurol Sci 2004;220:3-21.
27. Rusbridge C, MacSweeny J, Davies J, et al. Syringomyelia in the Cavalier King Charles spaniels. J Am Anim Hosp Assoc 2000;36:34-41.
28. Rusbridge C, Carruthers H, Dubé MP, Holmes M, Jeffery ND. Syringomyelia in Cavalier King Charles spaniels: The relationship between syrinx dimensions and pain. J Small Anim Pract 2007:48:432-436.
29. Milhorat TH, Kotzen RM, Mu HTM, Capocelli AL, Milhorat H. Dysesthetic pain in patients with syringomyelia. Neurosurgery 1996;35:940-947.
30. Ducreux D, Attal N, Parker F, Bouhassira D. Mechanisms of central neuropathic pain: A combined psychophysical and fMRI study in syringomyelia. Brain 2006;129:963-976.
31. De Broucker T, Cesaro P, Willer JC, Le Bars D. Diffuse noxious inhibitory controls in man. Involvement of the spinoreticular tract. Brain 1990;113:1223-34.
32. Kakigi R, Shibasaki H, Kuroda Y, et al. Pain-related somatosensory evoked potentials in syringomyelia. Brain 1991;114:1871-1889.
33. Costigan M, Woolf CJ. Pain: molecular mechanisms. J Pain 2000;1:35-44.
34. Yaksh TL. Behavioral and autonomic correlates of the tactile evoked allodynia produced by spinal glycine inhibition: Effects of modulatory receptor systems and excitatory amino acid antagonists. Pain 1989;37:111-123.
35. Neumann S, Doubell TP, Leslie T, Woolf CJ. Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons. Nature 1996;384:360-364.
36. Woolf CJ, Salter MW. Neuronal plasticity: Increasing the gain in pain. Science. 2000;288:1765-1769.
37. Ji RR, Woolf CJ. Neuronal plasticity and signal transduction in nociceptive neurons: Implications for the initiation and maintenance of pathological pain. Neurobiol Dis 2001;8:1-10.
38. Woolf CJ. Evidence for a central component of post-injury pain hypersensitivity. Nature 1983;306:686-688.
39. Marvizón JC, Grady EF, Stefani E, Bunnett NW, Mayer EA. Substance P release in the dorsal horn assessed by receptor internalization: NMDA receptors counteract a tonic inhibition by GABA(B) receptors. Eur J Neurosci 1999;2:417-426.
40. Woolf CJ. Dissecting out mechanisms responsible for peripheral neuropathic pain: Implications for diagnosis and therapy. Life Sci 2004;74:2605-2610.
41. Grossman R, Youssem, D. Techniques in neuroimaging. In: Neuroradiology - The Requisites. 2nd ed. Philadelphia: Mosby, 2003:1-35.
42. Tubbs RS, McGirt MJ, Oakes WJ. Surgical experience in 130 pediatric patients with chiari malformations. J Neurosurg 2003;99:291-296.
43. Dewey C, Berg J, Barone G, et al. Foramen magnum decompression for treatment of caudal occipital malformation syndrome in dogs. J Am Vet Med Assoc 2005;227:1270-1275.